Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma
Description
                Favipiravir (FVP) is a broad-spectrum antiviral that selectively inhibits viral RNA-dependent RNA polymerase, first trialled for the treatment of influenza infection. It has been shown to be effective against a number of RNA virus families including
          